GlassScriptPhysician profile
Dabney P Herrold
NPI 1033776497
$634.87
in general payments reported to CMS, 2019-2025
12 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.08 · 2022: $179 · 2023: $163 · 2024: $121 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $104.15 | 2022-2024 | |
| Exeltis, USA INC. | $101.07 | 2023-2025 | Slynd |
| Organon LLC | $87.30 | 2023-2025 | Nexplanon |
| Abbvie INC. | $86.90 | 2021-2022 | |
| Hologic Sales and Service, LLC | $74.21 | 2022-2025 | Novasure, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $48.82 | 2022 | |
| Biogen, INC. | $27.83 | 2025 | Zurzuvae |
| Tempus Ai, INC | $27.27 | 2024 | |
| Mayne Pharma Commercial LLC | $26.42 | 2023 | |
| Exact Sciences Corporation | $20.69 | 2025 | The Cologuard Plus Collection Kit |
| Shield Therapeutics INC | $16.05 | 2024 | |
| Urovant Sciences INC | $14.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dabney Herrold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.